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Most common diagnosis and therapeutic methods have low effectiveness when used on 
brain diseases. The key obstacle is that the blood-brain barrier (BBB) prevents most drugs from 
entering the brain. Some strategies have been developed to improve the efficiency of drug 
delivery crossing BBB. Among all these strategies, focused ultrasound-mediated BBB opening 
(FUS-BBB Opening) stands out since it is noninvasive and can be located to the target area. 
Detailed studies are required on the distribution of drugs delivered by FUS-BBB opening and the 
effects of FUS parameters on the distribution. This thesis proposes a pipeline involving tissue 
clearing and lightsheet microscopy to study the distribution of BSA relative to vessels in mouse 
brains treated with FUS and the effect of ultrasound pressure on the delivery pattern.  
As mentioned before, slices (1 mm thick) from mouse brains treated with FUS were cleared 
until their transparency meets the requirement of large-volume three-dimensional (3D) imaging. 
Blood vessels and BSA clusters in the 3D images obtained from lightsheet microscopy 
were segmented and the distance of every cluster from the nearest vessel was collected in the 




Comparing the distance maps of different pressures, it is indicated that FUS with the 
pressure of 0.4 MPa significantly increases the amount of BSA clusters in 
brains, especially those distributed closer to the outer surface of vessels. BSA delivered by 0.2 
MPa FUS and 0.4 MPa FUS has different distribution patterns relative to vessels. At the same time, 






Chapter 1: Introduction  
Background 
The brain is one of the most important organs of humans. Brain diseases, like central 
nervous system (CNS) diseases and brain cancers, are troubling many 
patients. In consequence, research about the physiological mechanism of the brain and the 
treatment of brain diseases has always attracted attention. However, due 
to the existence of the blood-brain barrier (BBB), drugs for brain diseases only have poor 
effects.(Dong, 2018) The advantages of FUS-BBB opening as noninvasive and localized 
have been validated for the delivery of therapeutic and imaging agents. The distribution of drugs 
is important to a drug delivery method since it not only plays a key role in clinical safety and 
efficiency but also helps us to understand the physiological process during the delivery. Pressure 
amplitude is a main parameter of FUS and has been proved to affect drug delivery crossing BBB. 
However, studies on the 3D distribution of drugs relative to neuron vascular under different 
pressures remain blank.   
Tissue clearing has been used to visualize the biodistribution of delivered materials in brain 
tissue as a pre-imaging processing technique because of its advantage in the visualization of 
intact tissue. Tissue clearing matches the refractive indices of different tissue layers and improves 
the transmission of light so that it can increase the imaging depth by removal of the light scattering 
and adsorbing substance.(Arms et al., 2020) On the other hand, it can still provide us 
with spatial information since it preserves the main structure constituted by proteins. Validated 
methods can make large samples transparent enough so that the imaging extent is only limited by 




achieve subcellular 3D imaging without deleterious sectioning on tissue and sophisticated data 
reconstruction so that we avoid mechanical distortion as much as possible.  
Drug Delivery Induced by FUS-BBB Opening  
            For a long time, how to cross (BBB) has always been the main obstacle 
to applying many diagnosis and therapeutic methods to brain diseases. Anatomically speaking, 
BBB is a continuous layer of endothelial cells (ECs) on cerebral vascular. These ECs bound to 
each other with tight junctions (TJs) and have extremely low rates of transcytosis compared with 
peripheral ECs, so that restricts the paracellular flux and vesicle-mediated transcellular movement 
of solutes.(Banks, 2008) ECs and their unique property to limit substance exchange between the 
vascular system and central nervous system (CNS) together constitute the physiological BBB. In 
the healthy brain, BBB is important to maintain the homeostasis of the CNS and protect it from 
toxins and pathogens. However, BBB also prevents most therapeutic materials and imaging agents 
circulating in the vasculature from arriving at the brain parenchyma, which reduces the efficiency 
of drug delivery and correspondingly increases the systematic toxicity. Some strategies have been 
developed to circumvent the BBB. However, intra-cerebral injection, use of implants or 
convection-enhanced delivery are invasive and raise significant safety concerns. Modifying 
drugs to take advantage the native BBB transport or transcytosis system requires excessive costs of 
designing new drugs.(Gabathuler, 2010) Other strategies involving viral vectors, non-viral 
nanoparticles and brain permeability enhancers have been indicated in recent publications that they 
may not have enough therapeutic effects at a reasonable dosage of drugs.(Dong, 2018)  
Focused ultrasound (FUS) combined with microbubbles (MBs) are discovered to be able 
to disrupt the integrity of BBB without apparent neuronal injury. Compared with other strategies, 




developed, the successful delivery by FUS-BBB opening has been verified for a wide range of 
therapeutic and imaging drugs, such as radiolabeled nanoclusters, liposomally-
encapsulated drugs and antibodies.  
MBs are small-sized (1-5 µm) gas-filled vesicles stabilized by phospholipids, proteins or 
polymers.(Dasgupta et al., 2016) Ultrasound is most well-known for its application 
on clinical noninvasive real-time imaging. With ultrasound, MBs in the neuronal vascular may 
contract, expand or burst, which will trigger a series of biophysical effects. The main consequence 
of these effects will be the transient opening of ECs and the TJs between ECs leading to the 
increase of microvascular permeability, thus improving the drug delivery across the BBB. In 
addition, soft- and hardware techniques on focused ultrasound can limit the BBB opening within 
small areas, improving the targeting of drug delivery and reducing the risk to the whole brain.  
The pressure amplitude of FUS is an important parameter to BBB opening. Increasing the 
pressure amplitude will increase the BBB permeability. With the same frequency, repetition 
frequency and total exposure time, higher pressure intend to cause the BBB opening 
at a larger area and the signal enhancement caused by the increase in the average delivery volume 
of the magnetic resonance imaging (MRI) contrast agent per unit area.(Chopra et al., 2010) 
The increase in pressure also tends to enlarge the BBB opening size, defined by the size of the 
largest molecule that can cross the BBB.(Chen & Konofagou, 2014) However, excessive pressure 
will cause tissue damage such as hemorrhage, necrotic and neuronal injury.(Chopra et al., 2010)  
Tissue Clearing  
The main principle of tissue clearing is the substitution of water in samples with 
the solutions that have higher RI, which is closer to the tissue. In this procedure, the key problem 




methods, some methods rely on chemical solvents and passive diffuse (passive and active 
CLARITY, SWITCH). Most tissue clearing methods can be divided into two groups based on the 
characteristic of the solvents they use: organic solvent (EtOH, THF)–based clearing methods 
(3DISCO, iDISCO) and hydrophilic reagent (urea, D-sorbitol, fructose)–based clearing methods 
(ScaleS, AbScale, CUBIC, FRUIT, UbasM, SeeDB). Although some organic solvent and amino 
alcohol already can solubilize lipids, some methods also add detergent (SDS, Triton X-100) into 
their recipe to improve the ability of lipid removal, therefore increase the transmission of light, 
such as CLARITY, SWITCH, AbScale and CUBIC. Active CLARITY involves electrophoresis 
to accelerate the penetration of detergent into tissue. Besides, although all methods require the 
tissue to be fixed before clearing, the tissue-hydrogel crosslinking with acrylamide 
in CLARITY provides more opportunity to retain protein and nanoparticles.  
All these tissue clearing methods have their advantages as well as shortages. The 
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Considering this study can be extended to observe the colocalization of BSA and neuron 
cells, the IHC compatibility, fluorescence preservation ability and nanoparticle preservation ability 
of these methods are mainly cared about. After carefully screening and balancing, we 
pick AbScale as our protocol. As shown in the table, AbScale is compatible with 
immunohistochemistry and can preserve most fluorescence by the end of tissue clearing. In the 
protocol of AbScale, reagent-1 (ScaleS0) can solubilize cholesterol of biological membrane with 
Methyl-β-cyclodextrin and γ-cyclodextrin and loosen collagen structure with N-acetyl-L-
hydroxyproline. After the incubation in ScaleS0, the fixed tissue becomes loose enough to 
exchange materials with the following reagents. Reagent-2 (ScaleA2) involves high concentration 
urea to prompt the molecule influx, Triton X-100 to extract lipids. Reagent-3 (ScaleB4) has a 2-
fold higher concentration of urea to clear the tissue quickly. Reagent-4 (ScaleS4) contains glycerol 
and DMSO for high RI (1.439). The molecule influx by urea and osmotically balanced molecule 
flux by D-sorbitol in ScaleS4 accelerate the penetration of the solution.  
So far there is a lack of reference on the loss of nanoparticles after clearing by AbScale. 
However, bovine serum albumin (BSA) as a kind of protein can be linked to the crosslinking 
formed by close endogenous proteins in the tissue through amino acids during fixation and post-
fixation. This process greatly improves the probability of the retention of delivered BSA after 
tissue clearing, thus providing our study with more accurate information. In addition, BSA is a 
competitive carrier of drugs, especially nanoparticle delivery drugs, so that involved in the therapy 
of many kinds of cancers.(Elzoghby et al., 2012) BSA is serum albumin derived from cows and 
has 583 amino acid residues. The molecule weight of BSA is 69323 Da. The dimension of a single 
BSA particle is 140 × 40 × 40 Å. BSA is rich in nature and easy to be purified. It also has the 




and non-immunogenicity. Last but not least, BSA nanoparticles can be prepared by 
simple coacervation.(Galisteo-González & Molina-Bolívar, 2014) Therefore, BSA is a good drug 






Chapter 2: Materials and Methods  
Animals  
Animal protocols used in this study were reviewed and approved by the Institutional 
Animal Care and Use Committee in accordance with the National Institutes of Health guidelines 
for animal research (approval no. 20180186; date of approval: 12 August 2019). Cr. NIH Swiss 
mice (6–8 weeks, ~25 g body weight, female) were ordered from Charles River Laboratory 
(Wilmington, MA, USA). The animals were housed in a room maintained at 22 °C and 55% 
relative humidity, with a 12-h/12-h light/dark cycle and access to standard laboratory chow and 
water.  
Drug Model  
Albumin from Bovine Serum conjugated with Alexa FluorTM 647 (BSA-AF647) 
was purchased from Thermo Fisher Scientific (Wilmington, DE, USA) and dissolved to 1.3 
mg/mL with 1x Phosphate Buffered Saline (PBS) when in use.  
FUS-BBB Opening Setup  






Figure 2.1 Workflow and timeline. 
 (a) Workflow. (b) Timeline.  
Experimental Procedure  
BSA-AF647 Delivery via FUS-BBB Opening  
6 mouses were anesthetized with a continuous flow of 2% isoflurane mixed with 
oxygen. Then BSA-AF647 (4.29 µg/kg) and microbubbles (5 x 108/kg) were injected into the 




MPa and 3 for 0.4 MPa). The frequency of the FUS transducer is 1.5 MHz After 15 mins, inject 
Lycopersicon Esculentum (Tomato) Lectin conjugated with DyLight 488 (Thermo 
Fisher Scientific, Wilmington, DE, USA) into the mouse via tail vein, followed by perfusion 
immediately.  
Transcardial Perfusion Fixation and Post-fixation  
The transcardial perfusion was completed by a perfusion pump with a speed of 5.5 mL/min. 
First, the blood was removed by 60 mL perfusion solution containing 1x PBS, 10 U/mL heparin 
and 0.5% w/v sodium nitrite (Sigma Aldrich, St. Louis, MO, USA). Then the tissue was fixed 
by perfusion with 50 mL fixation solution containing 1x PBS and 4% w/v paraformaldehyde (PFA) 
(Sigma Aldrich, St. Louis, MO, USA). After being harvested from the mouse, the mouse brain was 
incubated in 4% PFA/PBS at 4 °C for 10 hours.  
AbScale Clearing  
The fixed brains were sectioned as 1 mm thick slices. Before clearing, samples were 
imaged by Pearl Trilogy Small Animal Imager to record the BSA delivery results. 2 slices 
with a strong signal were selected to be cleared for each mouse.  
In this protocol, ScaleS0 solution is made by mixing 1x PBS, 20% w/v D-sorbitol (Sigma 
Aldrich, St. Louis, MO, USA), 1 mM Methyl-β-cyclodextrin (Sigma Aldrich, St. Louis, MO, 
USA), 1 mM γ-cyclodextrin (TCI Chemicals, Tokyo, Japan), N-acetyl-L-hydroxyproline 
(Oakwood Chemical, West Columbia, SC, USA), and 3% v/v Dimethyl sulfoxide (DMSO) and 
adjusting the pH to 7.2 with NaOH and HCl. ScaleA2 solution contains dd water, 10% w/v 
glycerol, 4 M urea and 0.1% Triton X-100.  ScaleB4 solution is 8 M aqueous urea in dd water. 
ScaleS4 solution contains dd water, 40% w/v D-sorbitol, 10% w/v glycerol, 4 M urea, 15% DMSO 




   
Selected slices were first incubated in ScaleS0 solution for 12 hours to permeabilize 
the samples. Then the incubation solution was changed to ScaleA2 for 36 hours, followed by 
ScaleB4 for 24 hours and changed back to ScaleA2 for another 12 hours. All incubation was 
at 37 °C with shaking. The samples were washed with 1x PBS at 4 °C for 6 hours. Finally, 
the samples were moved to ScaleS4 solution and incubated at 37 °C for 12 





Figure 2.2 Tissue opacity throughout the clearing process. 
Light-sheet Imaging  
After tissue clearing, samples were imaged with Pearl Trilogy Small Animal Imager to 
record the BSA delivery results again. One pair of regions of interest (ROIs) was selected from 
the slice with a stronger signal for each brain to be imaged with the lightsheet microscopy. Each 
pair of ROIs contains one region on the ipsilateral side with the strongest signal and one symmetry 
region on the contralateral side.  
3D imaging of clearing samples containing BSA-AF647 was done using the 
Zeiss Lightsheet 7 planar illumination microscope equipped with a 20X objective lens (NA=1, 
RI=1.46).   
The selected sample for each brain was taped to a sample holder by Loctite Super Glue and 
incubated in the chamber full of ScaleS4 solution. The z step size was 0.57 um. The size of 
each ROI was 450 × 450 × ~1500 µm (x, y, z). Raw images were collected from the ROI on the 
ipsilateral sides followed by the ROI on the contralateral sides.  
Image Analysis  
BSA Cluster and Vessel Segmentation  
Bitplane Imaris was used to analyze the raw images from lightsheet microscopy. Images 
were cropped to the size of 450 x 450 x 500 um. For each pair of images, the contralateral one was 
processed first. Surface, the built-in program in Imaris was used to segment vessels. According to 
the image of the lectin channel, vessels are segmented as intact as possible by adjusting the 
threshold. Then Spots function was used to detect BSA clusters. The threshold about mean 
intensity in the BSA channel was adjusted until there were no clusters in the space far from vessels. 




here. Vessels on the ipsilateral side were segmented independently while BSA clusters were 
detected by the same threshold as the contralateral side processed previously.  
Shortest Distance Map  
The shortest distance (Figure 2.3) from BSA clusters to vessel was automatically 
calculated by Imaris. The data was exported as Excel files and imported into GraphPad Prism 9 
for later analysis and statistical plotting.  
 








Chapter 3: Results  
Effect of Tissue Clearing on FUS-delivered BSA  
 
Figure 3.1 Fluorescence intensity in 2D images before and after tissue clearing, quantified by 
Pearl Trilogy Small Animal Imager and MATLAB code.  
The mean fluorescence intensity of the BSA channel on samples treated 0.2 MPa FUS 
(Figure 3.1) has reduced 35.4% after clearing compared with before clearing. This ratio for 0.4 




Quantification of BSA Clusters in 3D Images  
 
Figure 3.2 Representative 3D images of lectin-stained blood vessels and BSA in cleared brain 
slices.  
(a) Representative 3D images of the ROI on the contralateral side. The top figure is a top view and 




(c) Representative 3D images of the ROI on the ipsilateral side. Insets, 100 µm. The pressure of 
FUS used to treat this sample is 0.2 MPa.  
Cleared mouse slices were imaged by an ORCA-Flash4.0 V3 Digital CMOS camera to 
show the BSA distribution on the whole slice (Figure 3.2 b). Each pair of ROI includes one area 
on the ipsilateral side which has apparent BSA retention and an area symmetrical to it. The red 
box in Figure 3.2b describes the approximate location of the ROI. With the lightsheet microscope, 
we obtained one pair of 3D images with a cross-section of 450 × 450 µm and a depth 
of approximately 1.5 mm from the ipsilateral side (Figure 3.2 c) and the contralateral side (Figure 
3.2 a). The transparency of 1 mm-thick brain slices cleared with AbScale is enough for large 
volume 3D imaging. Under the same display setting, the BSA channel has apparently higher signal 
intensity on the ipsilateral side than the contralateral side. However, there is a lack of obvious 
difference of lectin between both sides. This indicates that BSA accumulated on the side treated 
with FUS within 15 minutes after the injection of BSA and the treatment of FUS. Since the size of 
the BSA single particle is much smaller than the resolution of the light sheet microscopy with 
20× objective (lateral resolution: 1~2 µm), it is only able to distinguish clusters formed by 





Figure 3.3 BSA cluster and blood vessel segmentation in representative 3D images.  
(a) Raw images and processed images with BSA cluster and blood vessel segmentation from the 
contralateral side. Raw images are in the first column. Yellow spots in the second column represent 
segmented BSA clusters. Green surfaces represent segmented blood vessels. (b) Raw images and 
processed images with BSA cluster and blood vessel segmentation from the ipsilateral side. Raw 
images are in the second column. Size of all 3D images, 450 x 450 x 500 um. The pressure of FUS 
used to treat this sample is 0.2 MPa.  
Compared to the raw image in Figure 3.3, the green surface is consistent with the 
distribution of blood vessels, showing that the vessel segmentation 
function can identify intact blood vessels stained with lectin and reflect their shape and spatial 
distribution. However, vessel segmentation faces difficulties in some areas where the fluorescence 




distributed on the ipsilateral side, which is consistent with what we observed in the raw image. 











(a) Raw images and processed images with BSA cluster and vessel segmentation from the 
contralateral side. Raw images are in the first column. Yellow spots in the second column represent 
segmented BSA clusters. Green surfaces represent segmented blood vessels. (b) Raw images and 
processed images with BSA cluster and blood vessel segmentation from the ipsilateral side. Raw 
images are in the second column. Size of all 3D images, 450 × 450 × 500 µm. The pressure of FUS 
used to treat this sample is 0.2 MPa.  
Characterization of the BSA Delivery with the Distance Map  
Peaks of all distance maps are located on the negative part of the x-axis, 
with a distance of around 1.5 µm to the zero points (Figure3.5). The differences in the peak 
locations among different conditions are insignificant. The location of the peak means where 
most BSA gathered. BSA uptake by vessels has been observed in untreated brains in the previous 
study.(Kucharz et al., 2021) It is acceptable to assume peaks in these distance maps are consistent 
with the location of vessels. However, lectin stains vessels on the luminal surface of ECs, 
(Robertson et al., 2015)  so theoretically, peaks should locate on the positive part of the x-
axis. Considering the resolution of lightsheet microscopy, this displacement can be explained by 
imaging artifacts.   
Based on the previous assumption, clusters on the left of the peak represent a part of those 
taken up by vessels (Figure 3.4a iii). Since their locations are closer to the inner surface of vessels, 
we define them as inner part clusters. Clusters on the right of the peak of the distance map include 
a part of clusters located in vessels but closer to the outer surface of vessels, clusters adhered to 
the outer surface of vessels, and clusters delivered out of vessels (Figure 3.4b iii), which we define 





Figure 3.5 Locations of peaks on distance maps of BSA clusters delivered by FUS with the 





Figure 3.6 Quantification of outer part BSA clusters delivered by FUS with the pressure of 0.4 
MPa and 0.2 MPa on the ipsilateral and contralateral sides. *P<0.05.  
Figure 3.6 characterizes the BSA delivery level of different FUS pressure by the amount of 
BSA clusters on the right of the peak of the distance map. 0.4 MPa FUS has significant 
improvement on the outer part BSA delivery, increasing the mean number of clusters by 6.97-fold 
compared with the contralateral side. The fold for 0.2 MPa FUS is 3.58. However, there is no 





Figure 3.7 Quantification of inner part BSA clusters delivered by FUS with the pressure of 0.4 
MPa and 0.2 MPa on the ipsilateral and contralateral sides. *P<0.05.  
Figure 3.7 characterizes the BSA delivery level of different FUS pressure by the amount of 
BSA clusters on the left of the peak of the distance map. 0.4 MPa FUS has significant improvement 
on the inner part BSA, increasing the mean number of clusters by 5.58-fold compared with the 
contralateral side. The fold for 0.2 MPa FUS is 2.52. However, there is no significant 






Figure 3.8 The ratio of outer part BSA clusters to all clusters in the brain. *P<0.05.  
Figure 3.8 characterizes the BSA delivery level of different FUS pressure by the ratio of 
BSA clusters on the right of the peak of the distance map to the total amount. 0.4 MPa FUS shows 
significant improvement on the outer part BSA delivery, increasing the mean ratio by 1.13-fold 





Figure 3.9 The ratio of inner part BSA clusters to all clusters in the brain. *P<0.05.  
Figure 3.9 characterizes the BSA delivery level of different FUS pressure by the ratio of 
BSA clusters on the left of the peak of the distance map to the total amount. 0.4 MPa FUS 
significantly decrease the ratio of clusters by 18.7% compared with the contralateral side, which 
implies 0.4 MPa FUS has more improvement on outer part BSA delivery than the inner part. The 







Figure 3.10 Quantification of BSA clusters delivered to mouse brains by FUS with the pressure 
of 0.4 MPa and 0.2 MPa.  
Figure 3.10 characterizes the BSA delivery level of different FUS pressure by the total 
amount of BSA clusters in the brain slice. 0.4 MPa FUS has significant improvement on the BSA 
delivery, increasing the mean number of clusters by 6.22-fold compared with the contralateral side. 
The fold for 0.2 MPa FUS is 3.19. However, it does not show a significant difference in this 
characteristic between 0.4 MPa and 0.2 MPa.  
Although 0.2 MPa shows a significant difference compared with 0.4 MPa in Figure 3.9 and 
Figure 3.10, this difference may come from individual variation among samples rather than 
delivery capacity. The ratio of inner part clusters should be the same on the contralateral sides of 
0.4 MPa samples and 0.2 MPa samples. However, in Figure 3.9 and Figure 3.10, there is an 




threshold for BSA segmentation is only kept consistent between both sides on one sample, and the 
change of the threshold can influence the number and even ratio of inner and outer part 
clusters. In consequence, it does not make sense to compare the ipsilateral sides of 0.4 MPa and 




Chapter 4: Conclusion  
Using the image analysis pipeline based on the shortest distance to analyze the 3D 
images of cleared brain slices following FUS treatment with different pressure, this study proved 
that 0.4 MPa FUS treatment can significantly enhance BSA delivery cross BBB, from both aspects 
of the inner part and outer part. whereas 0.2 MPa did not improve the delivery significantly. At the 
same time, this study also proved that this research pipeline has the potential to further study 




Chapter 5: Discussion  
Limited by the resolution of light sheet microscopy, only BSA clusters are studied in this 
thesis. Single BSA particles diffused out of blood vessels can cause stronger background. However, 
it is difficult to quantify BSA single particles by the signal intensity of the background, since the 
background in images from light sheet microscopy is also influenced by the transparency of the 
ROI and the distance from the light source to the ROI.  
BSA clusters far away from blood vessels mostly exist in the brain in the shape of 
ellipsoids. There is the possibility that those BSA were taken up by cells. In the future, 
immunostaining can be used to observe whether BSA clusters and some kinds of cells are co-
localized to validate this assumption.  
It's undeniable that this study has some direction that can be improved. Firstly, the number 
of replicates is not large enough, which might hide some information in the data. Secondly, 
although the wild filed microscope is used to select the ROI before 3D imaging, due to 
the different sizes of sample slices, it is difficult to accurately locate the ROI with the light sheet 
system after the sample is installed in the chamber. Establishing more rigorous installation 
procedures is expected to solve this problem. Besides, in the pilot study, 0.4 MPa FUS was used 
and BSA was allowed to cross the BBB for 1 hour. A more obvious contrast is observed on the 
ipsilateral side relative to the contralateral side. Reducing this time to 15 minutes has 
likely weakened the significance of the result. Last but not least, other experiments should be 
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